In a recent interview with Handelsblatt, Siemens AG’s CFO, Ralf Thomas, disclosed the company’s contemplation of its majority stake in Healthineers, its medical technology subsidiary. The evaluation stems from considerations of economic opportunities within the healthcare sector and the necessity of continued investment in Healthineers. This potential shift in strategy, estimated at 45 billion euros ($46.91 billion), could signal significant changes for Siemens as it reevaluates its holdings. Thomas hinted at possible divestiture to fund other ventures like acquiring Altair, underscoring the dynamic nature of Siemens’ investment decisions. As shareholders eagerly await further developments, all eyes are on Siemens’ upcoming capital markets day in late 2025 for key revelations and strategic insights.
0
Your cart is empty
About Us
The argument in favor of using filler text goes something like this: If you use arey real content in the Consulting Process anytime you reachtent.
Contact Info
Chicago 12, Melborne City, USA [email protected] (123)-333-000-999Follow Us
Leave feedback about this